Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-06-07
1997-10-14
Nazario-Gonzalez, Porfirio
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514486, 514512, 514513, 514533, 514534, 514538, 514833, 548403, 548416, 548473, 548478, 562425, 562452, 562455, A61K 3140, C07D20948, C07D22900
Patent
active
056773307
ABSTRACT:
A family of compounds has been found to be useful for right-shifting hemoglobin towards a low oxygen affinity state. The effect has particular application in a wide variety of treatments including hypoxia, hypothermia, ischemia, stroke, ARDS, COPD, surgical blood loss, acute nonvolemic hemodilutions, wounds, diabetic ulcers, chronic leg ulcers, pressure sores, tissue transplants, and sepsis. The compounds are capable of acting on hemoglobin in whole blood.
REFERENCES:
patent: 5049695 (1991-09-01), Abraham et al.
patent: 5122539 (1992-06-01), Abraham et al.
patent: 5248785 (1993-09-01), Abraham et al.
patent: 5290803 (1994-03-01), Abraham et al.
Abraham Donald J.
Gerber Michael
Allos Therapeutics, Inc.
Nazario-Gonzalez Porfirio
The Center for Innovative Technology
LandOfFree
Medical uses of allosteric hemoglobin modifier compounds in pati does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Medical uses of allosteric hemoglobin modifier compounds in pati, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Medical uses of allosteric hemoglobin modifier compounds in pati will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555651